Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices

Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices

Bibliographic Details
Main Authors:	Ramon Andrade De Mello, António Araújo
Format:	Article
Language:	English
Published:	Elsevier España 2012-11-01
Series:	Clinics
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012001100022

Similar Items

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O’Leary, et al.
Published: (2020-09-01)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
by: Wei Zhao, et al.
Published: (2022-11-01)

A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency
by: Kunihiko Miyazaki, et al.
Published: (2022-03-01)

Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population
by: Gaye Güler Tezel, et al.
Published: (2017-12-01)

Bone metastases tend to increase in non-small cell lung cancer with epidermal growth factor receptor mutation
by: Reginald Maleachi, et al.
Published: (2022-01-01)

Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients
by: Liam, C.K., et al.
Published: (2013)

Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
by: Gina Amanda, et al.
Published: (2017-01-01)

Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection
by: Saumya Shukla, et al.
Published: (2022-01-01)

The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases
by: Kazuhiro Usui, et al.
Published: (2011-01-01)

A prospective study on epidermal growth factor receptor mutations in non-small cell lung cancer in Malaysian patients
by: Liam, C K, et al.
Published: (2012)

Evaluation of current methods to detect the mutations of epidermal growth factor receptor in non-small cell lung cancer patients
by: Obradovic Jasmina, et al.
Published: (2012-12-01)

Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer
by: Yuan-Ming Tsai, et al.
Published: (2022-01-01)

Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
by: Huang HM, et al.
Published: (2022-12-01)

Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
by: Ning Li, et al.
Published: (2022-01-01)

Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor  Receptor Mutations in Non-small Cell Lung Cancer
by: Xue YANG, et al.
Published: (2015-08-01)

Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer
by: Shinichiro Okauchi, et al.
Published: (2022-06-01)

Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study
by: John WC Chang, et al.
Published: (2015-06-01)

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
by: Carlos E. Bacchi, et al.
Published: (2012-01-01)

A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients
by: Cheng-Cheng Hwang, et al.
Published: (2022-09-01)

Could Radiomic Signature on Chest CT Predict Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer?
by: Ayten Kayi Cangir, et al.
Published: (2024-10-01)

Value of rebiopsy in advanced Epidermal Growth Factor Receptor mutated Non-Small Cell Lung Cancer: Real-world data
by: R. Saúde-Conde, et al.
Published: (2021-03-01)

Analysis of tumor abnormal protein expression and epidermal growth factor receptor mutation status in non-small cell lung cancer
by: Yuanjun Cheng, et al.
Published: (2024-07-01)

Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
by: Kensuke Kanaoka, et al.
Published: (2023-09-01)

Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer
by: Qian Yu, et al.
Published: (2023-09-01)

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation
by: How-Wen Ko, et al.
Published: (2022-10-01)

Targeted Therapy and Mechanism of Drug Resistance in Non-small Cell Lung Cancer  with Epidermal Growth Factor Receptor Gene Mutation
by: Junxia HUANG, et al.
Published: (2022-03-01)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
by: Tristan A. Barnes, et al.
Published: (2017-05-01)

Protein expression, gene amplification, epidermal growth factor receptor mutations and lung carcinoma
by: Panjković Milana, et al.
Published: (2014-01-01)

Subdural hematoma due to skull base bone metastasis of epidermal growth factor receptor mutated non‐small cell lung cancer
by: Tomohiko Oka, et al.
Published: (2024-07-01)

Deep learning–radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients
by: Seonhwa Kim, et al.
Published: (2024-01-01)

Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients
by: Lanlan Liu, et al.
Published: (2021-12-01)

Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma
by: Michelle Levy, et al.
Published: (2017-12-01)

Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients
by: Ng, Tiffany Shi Yeen, et al.
Published: (2013)

OPTIMAL SEQUENCE OF APPLICATION OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVATING EGFR MUTATIONS
by: A. A. Kolomeytseva, et al.
Published: (2020-12-01)

Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations
by: Jinfei Si, et al.
Published: (2023-05-01)

Optimizing the Treatment for Advanced Non–Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries: A Review
by: Mousa Alali, et al.
Published: (2023-08-01)

Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor
by: J. Machado-Rugolo, et al.
Published: (2023-01-01)

Osimertinib-Centered Therapy Against Uncommon Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer- A Mini Review
by: Chengyang Song, et al.
Published: (2022-04-01)

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer
by: Na Hu, et al.
Published: (2022-10-01)

Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
by: Sang Hwa Lee, et al.
Published: (2015-11-01)